51 |
FIM Results with a PC-coated Angiopeptin-Eluting Stent: Angiographic and IVUS Results |
Vincent On-Hing Kwok |
Jul. 16. 04 |
50 |
A Paclitaxel-Eluting Stent from India: the Infinnium SIMPLE-I Trial Results |
D.S. Gambhir |
Jul. 16. 04 |
49 |
New Drug-Eluting Stents: Everolimus (FUTURE-I and -II) and More |
Eberhard Grube |
Jul. 09. 04 |
48 |
Should We Expect "Late Catch-up"(Late Restenosis) After DES Treatment-Is the Genie Already out of the Bottle? You Have Simply Postponed the Inevitable |
Renu Virmani |
Jun. 18. 04 |
47 |
Intravascular Ultrasound Imaging and Physiologic Lesion Assessment in a Drug-Eluting Stent World |
Gary S. Mintz |
Jun. 11. 04 |
46 |
Tips of TRI |
Motomaru Masutani |
Jun. 04. 04 |
45 |
The Data First: Results of Studies Comparing Transradial and Femoral Angiography and PCI |
Howard A. Cohen |
May. 28. 04 |
44 |
The Program of DES of SORIN-Biomedica |
Gian Battista Danzi |
May. 21. 04 |
43 |
A Pro-healing Approach to Stent Thrombo-resistance and Restenosis Prevention: Endothelial Progenitor Cell Capture |
Michael Kutryk |
May. 13. 04 |
42 |
The TAXUS-IV "Mega-trial": Insights from Subgroup Analyses |
Stephen G. Ellis |
May. 07. 04 |